Cargando…

Open vascular treatment of median arcuate ligament syndrome

BACKGROUND: Median arcuate ligament syndrome is a rare condition with abdominal symptoms. Accepted treatment options are open release of median arcuate ligament, laparoscopic release of edian arcuate ligament, robot-assisted release of median arcuate ligament and open vascular treatment. Here we aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Duran, Mansur, Simon, Florian, Ertas, Neslihan, Schelzig, Hubert, Floros, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575896/
https://www.ncbi.nlm.nih.gov/pubmed/28851450
http://dx.doi.org/10.1186/s12893-017-0289-8
_version_ 1783260124844916736
author Duran, Mansur
Simon, Florian
Ertas, Neslihan
Schelzig, Hubert
Floros, Nikolaos
author_facet Duran, Mansur
Simon, Florian
Ertas, Neslihan
Schelzig, Hubert
Floros, Nikolaos
author_sort Duran, Mansur
collection PubMed
description BACKGROUND: Median arcuate ligament syndrome is a rare condition with abdominal symptoms. Accepted treatment options are open release of median arcuate ligament, laparoscopic release of edian arcuate ligament, robot-assisted release of median arcuate ligament and open vascular treatment. Here we aimed to evaluate the central priority of open vascular therapy in the treatment of median arcuate ligament syndrome. METHODS: We conducted a monocentric retrospective study between January 1996 and June 2016. Thirty-one patients with median arcuate ligament syndrome underwent open vascular surgery, including division of median arcuate ligament in 17 cases, and vascular reconstruction of the celiac artery in 14 cases. RESULTS: In a 20-year period, 31 patients (n = 26 women, n = 5 men) were treated with division of median arcuate ligament (n = 17) or vascular reconstruction in combination with division of median arcuate ligament (n = 14). The mean age of patients was 44.8 ± 15.13 years. The complication rate was 16.1% (n = 5). Revisions were performed in 4 cases. The 30-day mortality rate was 0%. The mean in-hospital stay was 10.7 days. Follow-up data were obtained for 30 patients. The mean follow-up period was 52.2 months (range 2–149 months). Patients were grouped into a decompression group (n = 17) and revascularisation group (n = 13). The estimated Freedom From Symptoms rates were 93.3, 77.8, and 69.1% for the decompression group and 100, 83.3, and 83.3% for the revascularisation group after 12, 24 and 60 months respectively. We found no significant difference in the Freedom From Re-Intervention CA rates of the decompression (100% at 12, 24 and 60 months post-surgery) and revascularisation (100% at 12 months, and 91.7% at 24 and 60 months post-surgery) groups during follow-up (p = 0.26). CONCLUSIONS: Open vascular treatment of median arcuate ligament syndrome is a safe, low mortality-risk procedure, with low morbidity rate. Treatment choice depends on the clinical and morphological situation of each patient.
format Online
Article
Text
id pubmed-5575896
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-55758962017-08-30 Open vascular treatment of median arcuate ligament syndrome Duran, Mansur Simon, Florian Ertas, Neslihan Schelzig, Hubert Floros, Nikolaos BMC Surg Research Article BACKGROUND: Median arcuate ligament syndrome is a rare condition with abdominal symptoms. Accepted treatment options are open release of median arcuate ligament, laparoscopic release of edian arcuate ligament, robot-assisted release of median arcuate ligament and open vascular treatment. Here we aimed to evaluate the central priority of open vascular therapy in the treatment of median arcuate ligament syndrome. METHODS: We conducted a monocentric retrospective study between January 1996 and June 2016. Thirty-one patients with median arcuate ligament syndrome underwent open vascular surgery, including division of median arcuate ligament in 17 cases, and vascular reconstruction of the celiac artery in 14 cases. RESULTS: In a 20-year period, 31 patients (n = 26 women, n = 5 men) were treated with division of median arcuate ligament (n = 17) or vascular reconstruction in combination with division of median arcuate ligament (n = 14). The mean age of patients was 44.8 ± 15.13 years. The complication rate was 16.1% (n = 5). Revisions were performed in 4 cases. The 30-day mortality rate was 0%. The mean in-hospital stay was 10.7 days. Follow-up data were obtained for 30 patients. The mean follow-up period was 52.2 months (range 2–149 months). Patients were grouped into a decompression group (n = 17) and revascularisation group (n = 13). The estimated Freedom From Symptoms rates were 93.3, 77.8, and 69.1% for the decompression group and 100, 83.3, and 83.3% for the revascularisation group after 12, 24 and 60 months respectively. We found no significant difference in the Freedom From Re-Intervention CA rates of the decompression (100% at 12, 24 and 60 months post-surgery) and revascularisation (100% at 12 months, and 91.7% at 24 and 60 months post-surgery) groups during follow-up (p = 0.26). CONCLUSIONS: Open vascular treatment of median arcuate ligament syndrome is a safe, low mortality-risk procedure, with low morbidity rate. Treatment choice depends on the clinical and morphological situation of each patient. BioMed Central 2017-08-29 /pmc/articles/PMC5575896/ /pubmed/28851450 http://dx.doi.org/10.1186/s12893-017-0289-8 Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Duran, Mansur
Simon, Florian
Ertas, Neslihan
Schelzig, Hubert
Floros, Nikolaos
Open vascular treatment of median arcuate ligament syndrome
title Open vascular treatment of median arcuate ligament syndrome
title_full Open vascular treatment of median arcuate ligament syndrome
title_fullStr Open vascular treatment of median arcuate ligament syndrome
title_full_unstemmed Open vascular treatment of median arcuate ligament syndrome
title_short Open vascular treatment of median arcuate ligament syndrome
title_sort open vascular treatment of median arcuate ligament syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575896/
https://www.ncbi.nlm.nih.gov/pubmed/28851450
http://dx.doi.org/10.1186/s12893-017-0289-8
work_keys_str_mv AT duranmansur openvasculartreatmentofmedianarcuateligamentsyndrome
AT simonflorian openvasculartreatmentofmedianarcuateligamentsyndrome
AT ertasneslihan openvasculartreatmentofmedianarcuateligamentsyndrome
AT schelzighubert openvasculartreatmentofmedianarcuateligamentsyndrome
AT florosnikolaos openvasculartreatmentofmedianarcuateligamentsyndrome